Global Nonalcoholic Steatohepatitis (NASH) Market Research Report 2026(Status and Outlook)
Non-alcoholic steatohepatitis (NASH), is one of the common liver diseases, often called silent liver disease. The major feature in NASH is fat deposition in the liver, along with inflammation.Non-alcoholic drinks, also known as mocktails or alcohol-free beverages, are beverages that do not contain any alcohol. These drinks are a popular choice for those who do not consume alcohol, including designated drivers, people who are underage, or individuals who wish to avoid alcohol for personal or health reasons. There are a wide variety of non-alcoholic drinks available, ranging from soft drinks to fresh juices, herbal infusions, and specialty mocktails. Some examples of non-alcoholic drinks include: 1. Soft Drinks: This category includes popular carbonated beverages like cola, lemon-lime sodas, ginger ale, and root beer. These drinks are often sweet and fizzy, providing a refreshing and enjoyable beverage option. 2. Fruit Juices: Freshly squeezed or packaged fruit juices, such as orange, apple, grapefruit, pineapple, or cranberry juice, are a common choice. These juices offer a natural and flavorful alternative to alcoholic beverages. 3. Smoothies: Made from a blend of fruits, vegetables, yogurt, and other ingredients, smoothies provide a nutritious and wholesome non-alcoholic option. They can be customized with various flavors and ingredients to suit individual preferences. 4. Herbal Infusions and Tea: Herbal teas and infusions, such as chamomile, peppermint, green tea, or hibiscus tea, are popular choices. These beverages are caffeine-free and often have relaxing or soothing properties. 5. Mocktails: These are non-alcoholic cocktails that mimic the flavors and presentation of traditional cocktails. They are typically made with a combination of juices, sodas, and garnishes, providing a fancy and enjoyable experience without the alcohol. 6. Sparkling Water: Carbonated water or mineral water with added flavors or fruit infusions is a refreshing and hydrating option. It is often consumed plain or mixed with juices or syrups. These non-alcoholic drinks offer a variety of flavors, textures, and options for those who prefer not to consume alcohol. They are a great way to enjoy a beverage while socializing or relaxing without the effects of alcohol.
The global Nonalcoholic Steatohepatitis (NASH) market size was estimated at USD 6587.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 46.70% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Nonalcoholic Steatohepatitis (NASH) market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Nonalcoholic Steatohepatitis (NASH) market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Nonalcoholic Steatohepatitis (NASH) market.
Global Nonalcoholic Steatohepatitis (NASH) Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
AstraZeneca
Arena Pharmaceuticals
GSK
Novo Nordisk
Roche
Vivus
Arisaph Pharmaceuticals
Cempra Pharmaceuticals
Galectin Therapeutics
Galmed Pharmaceuticals
Genfit
Gilead
Market Segmentation (by Type)
Obeticholic acid?OCA?
Selonsertib
Market Segmentation (by Application)
Hospital Pharmacy
Online Provider
Retail Pharmacy
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Nonalcoholic Steatohepatitis (NASH) Market
Overview of the regional outlook of the Nonalcoholic Steatohepatitis (NASH) Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Nonalcoholic Steatohepatitis (NASH) Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Nonalcoholic Steatohepatitis (NASH), their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
The global Nonalcoholic Steatohepatitis (NASH) market size was estimated at USD 6587.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 46.70% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Nonalcoholic Steatohepatitis (NASH) market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Nonalcoholic Steatohepatitis (NASH) market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Nonalcoholic Steatohepatitis (NASH) market.
Global Nonalcoholic Steatohepatitis (NASH) Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
AstraZeneca
Arena Pharmaceuticals
GSK
Novo Nordisk
Roche
Vivus
Arisaph Pharmaceuticals
Cempra Pharmaceuticals
Galectin Therapeutics
Galmed Pharmaceuticals
Genfit
Gilead
Market Segmentation (by Type)
Obeticholic acid?OCA?
Selonsertib
Market Segmentation (by Application)
Hospital Pharmacy
Online Provider
Retail Pharmacy
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Nonalcoholic Steatohepatitis (NASH) Market
Overview of the regional outlook of the Nonalcoholic Steatohepatitis (NASH) Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Nonalcoholic Steatohepatitis (NASH) Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Nonalcoholic Steatohepatitis (NASH), their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Nonalcoholic Steatohepatitis (NASH)
1.2 Key Market Segments
1.2.1 Nonalcoholic Steatohepatitis (NASH) Segment by Type
1.2.2 Nonalcoholic Steatohepatitis (NASH) Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 NONALCOHOLIC STEATOHEPATITIS (NASH) MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Nonalcoholic Steatohepatitis (NASH) Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Nonalcoholic Steatohepatitis (NASH) Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 NONALCOHOLIC STEATOHEPATITIS (NASH) MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Nonalcoholic Steatohepatitis (NASH) Product Life Cycle
3.3 Global Nonalcoholic Steatohepatitis (NASH) Sales by Manufacturers (2020-2025)
3.4 Global Nonalcoholic Steatohepatitis (NASH) Revenue Market Share by Manufacturers (2020-2025)
3.5 Nonalcoholic Steatohepatitis (NASH) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Nonalcoholic Steatohepatitis (NASH) Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Nonalcoholic Steatohepatitis (NASH) Market Competitive Situation and Trends
3.8.1 Nonalcoholic Steatohepatitis (NASH) Market Concentration Rate
3.8.2 Global 5 and 10 Largest Nonalcoholic Steatohepatitis (NASH) Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 NONALCOHOLIC STEATOHEPATITIS (NASH) INDUSTRY CHAIN ANALYSIS
4.1 Nonalcoholic Steatohepatitis (NASH) Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF NONALCOHOLIC STEATOHEPATITIS (NASH) MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Nonalcoholic Steatohepatitis (NASH) Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Nonalcoholic Steatohepatitis (NASH) Market
5.7 ESG Ratings of Leading Companies
6 NONALCOHOLIC STEATOHEPATITIS (NASH) MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Nonalcoholic Steatohepatitis (NASH) Sales Market Share by Type (2020-2025)
6.3 Global Nonalcoholic Steatohepatitis (NASH) Market Size by Type (2020-2025)
6.4 Global Nonalcoholic Steatohepatitis (NASH) Price by Type (2020-2025)
7 NONALCOHOLIC STEATOHEPATITIS (NASH) MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Nonalcoholic Steatohepatitis (NASH) Market Sales by Application (2020-2025)
7.3 Global Nonalcoholic Steatohepatitis (NASH) Market Size (M USD) by Application (2020-2025)
7.4 Global Nonalcoholic Steatohepatitis (NASH) Sales Growth Rate by Application (2020-2025)
8 NONALCOHOLIC STEATOHEPATITIS (NASH) MARKET SALES BY REGION
8.1 Global Nonalcoholic Steatohepatitis (NASH) Sales by Region
8.1.1 Global Nonalcoholic Steatohepatitis (NASH) Sales by Region
8.1.2 Global Nonalcoholic Steatohepatitis (NASH) Sales Market Share by Region
8.2 Global Nonalcoholic Steatohepatitis (NASH) Market Size by Region
8.2.1 Global Nonalcoholic Steatohepatitis (NASH) Market Size by Region
8.2.2 Global Nonalcoholic Steatohepatitis (NASH) Market Size by Region
8.3 North America
8.3.1 North America Nonalcoholic Steatohepatitis (NASH) Sales by Country
8.3.2 North America Nonalcoholic Steatohepatitis (NASH) Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Nonalcoholic Steatohepatitis (NASH) Sales by Country
8.4.2 Europe Nonalcoholic Steatohepatitis (NASH) Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Nonalcoholic Steatohepatitis (NASH) Sales by Region
8.5.2 Asia Pacific Nonalcoholic Steatohepatitis (NASH) Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Nonalcoholic Steatohepatitis (NASH) Sales by Country
8.6.2 South America Nonalcoholic Steatohepatitis (NASH) Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Nonalcoholic Steatohepatitis (NASH) Sales by Region
8.7.2 Middle East and Africa Nonalcoholic Steatohepatitis (NASH) Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 NONALCOHOLIC STEATOHEPATITIS (NASH) MARKET PRODUCTION BY REGION
9.1 Global Production of Nonalcoholic Steatohepatitis (NASH) by Region(2020-2025)
9.2 Global Nonalcoholic Steatohepatitis (NASH) Revenue Market Share by Region (2020-2025)
9.3 Global Nonalcoholic Steatohepatitis (NASH) Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Nonalcoholic Steatohepatitis (NASH) Production
9.4.1 North America Nonalcoholic Steatohepatitis (NASH) Production Growth Rate (2020-2025)
9.4.2 North America Nonalcoholic Steatohepatitis (NASH) Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Nonalcoholic Steatohepatitis (NASH) Production
9.5.1 Europe Nonalcoholic Steatohepatitis (NASH) Production Growth Rate (2020-2025)
9.5.2 Europe Nonalcoholic Steatohepatitis (NASH) Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Nonalcoholic Steatohepatitis (NASH) Production (2020-2025)
9.6.1 Japan Nonalcoholic Steatohepatitis (NASH) Production Growth Rate (2020-2025)
9.6.2 Japan Nonalcoholic Steatohepatitis (NASH) Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Nonalcoholic Steatohepatitis (NASH) Production (2020-2025)
9.7.1 China Nonalcoholic Steatohepatitis (NASH) Production Growth Rate (2020-2025)
9.7.2 China Nonalcoholic Steatohepatitis (NASH) Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 AstraZeneca
10.1.1 AstraZeneca Basic Information
10.1.2 AstraZeneca Nonalcoholic Steatohepatitis (NASH) Product Overview
10.1.3 AstraZeneca Nonalcoholic Steatohepatitis (NASH) Product Market Performance
10.1.4 AstraZeneca Business Overview
10.1.5 AstraZeneca SWOT Analysis
10.1.6 AstraZeneca Recent Developments
10.2 Arena Pharmaceuticals
10.2.1 Arena Pharmaceuticals Basic Information
10.2.2 Arena Pharmaceuticals Nonalcoholic Steatohepatitis (NASH) Product Overview
10.2.3 Arena Pharmaceuticals Nonalcoholic Steatohepatitis (NASH) Product Market Performance
10.2.4 Arena Pharmaceuticals Business Overview
10.2.5 Arena Pharmaceuticals SWOT Analysis
10.2.6 Arena Pharmaceuticals Recent Developments
10.3 GSK
10.3.1 GSK Basic Information
10.3.2 GSK Nonalcoholic Steatohepatitis (NASH) Product Overview
10.3.3 GSK Nonalcoholic Steatohepatitis (NASH) Product Market Performance
10.3.4 GSK Business Overview
10.3.5 GSK SWOT Analysis
10.3.6 GSK Recent Developments
10.4 Novo Nordisk
10.4.1 Novo Nordisk Basic Information
10.4.2 Novo Nordisk Nonalcoholic Steatohepatitis (NASH) Product Overview
10.4.3 Novo Nordisk Nonalcoholic Steatohepatitis (NASH) Product Market Performance
10.4.4 Novo Nordisk Business Overview
10.4.5 Novo Nordisk Recent Developments
10.5 Roche
10.5.1 Roche Basic Information
10.5.2 Roche Nonalcoholic Steatohepatitis (NASH) Product Overview
10.5.3 Roche Nonalcoholic Steatohepatitis (NASH) Product Market Performance
10.5.4 Roche Business Overview
10.5.5 Roche Recent Developments
10.6 Vivus
10.6.1 Vivus Basic Information
10.6.2 Vivus Nonalcoholic Steatohepatitis (NASH) Product Overview
10.6.3 Vivus Nonalcoholic Steatohepatitis (NASH) Product Market Performance
10.6.4 Vivus Business Overview
10.6.5 Vivus Recent Developments
10.7 Arisaph Pharmaceuticals
10.7.1 Arisaph Pharmaceuticals Basic Information
10.7.2 Arisaph Pharmaceuticals Nonalcoholic Steatohepatitis (NASH) Product Overview
10.7.3 Arisaph Pharmaceuticals Nonalcoholic Steatohepatitis (NASH) Product Market Performance
10.7.4 Arisaph Pharmaceuticals Business Overview
10.7.5 Arisaph Pharmaceuticals Recent Developments
10.8 Cempra Pharmaceuticals
10.8.1 Cempra Pharmaceuticals Basic Information
10.8.2 Cempra Pharmaceuticals Nonalcoholic Steatohepatitis (NASH) Product Overview
10.8.3 Cempra Pharmaceuticals Nonalcoholic Steatohepatitis (NASH) Product Market Performance
10.8.4 Cempra Pharmaceuticals Business Overview
10.8.5 Cempra Pharmaceuticals Recent Developments
10.9 Galectin Therapeutics
10.9.1 Galectin Therapeutics Basic Information
10.9.2 Galectin Therapeutics Nonalcoholic Steatohepatitis (NASH) Product Overview
10.9.3 Galectin Therapeutics Nonalcoholic Steatohepatitis (NASH) Product Market Performance
10.9.4 Galectin Therapeutics Business Overview
10.9.5 Galectin Therapeutics Recent Developments
10.10 Galmed Pharmaceuticals
10.10.1 Galmed Pharmaceuticals Basic Information
10.10.2 Galmed Pharmaceuticals Nonalcoholic Steatohepatitis (NASH) Product Overview
10.10.3 Galmed Pharmaceuticals Nonalcoholic Steatohepatitis (NASH) Product Market Performance
10.10.4 Galmed Pharmaceuticals Business Overview
10.10.5 Galmed Pharmaceuticals Recent Developments
10.11 Genfit
10.11.1 Genfit Basic Information
10.11.2 Genfit Nonalcoholic Steatohepatitis (NASH) Product Overview
10.11.3 Genfit Nonalcoholic Steatohepatitis (NASH) Product Market Performance
10.11.4 Genfit Business Overview
10.11.5 Genfit Recent Developments
10.12 Gilead
10.12.1 Gilead Basic Information
10.12.2 Gilead Nonalcoholic Steatohepatitis (NASH) Product Overview
10.12.3 Gilead Nonalcoholic Steatohepatitis (NASH) Product Market Performance
10.12.4 Gilead Business Overview
10.12.5 Gilead Recent Developments
11 NONALCOHOLIC STEATOHEPATITIS (NASH) MARKET FORECAST BY REGION
11.1 Global Nonalcoholic Steatohepatitis (NASH) Market Size Forecast
11.2 Global Nonalcoholic Steatohepatitis (NASH) Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Nonalcoholic Steatohepatitis (NASH) Market Size Forecast by Country
11.2.3 Asia Pacific Nonalcoholic Steatohepatitis (NASH) Market Size Forecast by Region
11.2.4 South America Nonalcoholic Steatohepatitis (NASH) Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Nonalcoholic Steatohepatitis (NASH) by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Nonalcoholic Steatohepatitis (NASH) Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Nonalcoholic Steatohepatitis (NASH) by Type (2026-2035)
12.1.2 Global Nonalcoholic Steatohepatitis (NASH) Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Nonalcoholic Steatohepatitis (NASH) by Type (2026-2035)
12.2 Global Nonalcoholic Steatohepatitis (NASH) Market Forecast by Application (2026-2035)
12.2.1 Global Nonalcoholic Steatohepatitis (NASH) Sales (K Units) Forecast by Application
12.2.2 Global Nonalcoholic Steatohepatitis (NASH) Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Nonalcoholic Steatohepatitis (NASH)
1.2 Key Market Segments
1.2.1 Nonalcoholic Steatohepatitis (NASH) Segment by Type
1.2.2 Nonalcoholic Steatohepatitis (NASH) Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 NONALCOHOLIC STEATOHEPATITIS (NASH) MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Nonalcoholic Steatohepatitis (NASH) Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Nonalcoholic Steatohepatitis (NASH) Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 NONALCOHOLIC STEATOHEPATITIS (NASH) MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Nonalcoholic Steatohepatitis (NASH) Product Life Cycle
3.3 Global Nonalcoholic Steatohepatitis (NASH) Sales by Manufacturers (2020-2025)
3.4 Global Nonalcoholic Steatohepatitis (NASH) Revenue Market Share by Manufacturers (2020-2025)
3.5 Nonalcoholic Steatohepatitis (NASH) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Nonalcoholic Steatohepatitis (NASH) Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Nonalcoholic Steatohepatitis (NASH) Market Competitive Situation and Trends
3.8.1 Nonalcoholic Steatohepatitis (NASH) Market Concentration Rate
3.8.2 Global 5 and 10 Largest Nonalcoholic Steatohepatitis (NASH) Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 NONALCOHOLIC STEATOHEPATITIS (NASH) INDUSTRY CHAIN ANALYSIS
4.1 Nonalcoholic Steatohepatitis (NASH) Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF NONALCOHOLIC STEATOHEPATITIS (NASH) MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Nonalcoholic Steatohepatitis (NASH) Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Nonalcoholic Steatohepatitis (NASH) Market
5.7 ESG Ratings of Leading Companies
6 NONALCOHOLIC STEATOHEPATITIS (NASH) MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Nonalcoholic Steatohepatitis (NASH) Sales Market Share by Type (2020-2025)
6.3 Global Nonalcoholic Steatohepatitis (NASH) Market Size by Type (2020-2025)
6.4 Global Nonalcoholic Steatohepatitis (NASH) Price by Type (2020-2025)
7 NONALCOHOLIC STEATOHEPATITIS (NASH) MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Nonalcoholic Steatohepatitis (NASH) Market Sales by Application (2020-2025)
7.3 Global Nonalcoholic Steatohepatitis (NASH) Market Size (M USD) by Application (2020-2025)
7.4 Global Nonalcoholic Steatohepatitis (NASH) Sales Growth Rate by Application (2020-2025)
8 NONALCOHOLIC STEATOHEPATITIS (NASH) MARKET SALES BY REGION
8.1 Global Nonalcoholic Steatohepatitis (NASH) Sales by Region
8.1.1 Global Nonalcoholic Steatohepatitis (NASH) Sales by Region
8.1.2 Global Nonalcoholic Steatohepatitis (NASH) Sales Market Share by Region
8.2 Global Nonalcoholic Steatohepatitis (NASH) Market Size by Region
8.2.1 Global Nonalcoholic Steatohepatitis (NASH) Market Size by Region
8.2.2 Global Nonalcoholic Steatohepatitis (NASH) Market Size by Region
8.3 North America
8.3.1 North America Nonalcoholic Steatohepatitis (NASH) Sales by Country
8.3.2 North America Nonalcoholic Steatohepatitis (NASH) Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Nonalcoholic Steatohepatitis (NASH) Sales by Country
8.4.2 Europe Nonalcoholic Steatohepatitis (NASH) Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Nonalcoholic Steatohepatitis (NASH) Sales by Region
8.5.2 Asia Pacific Nonalcoholic Steatohepatitis (NASH) Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Nonalcoholic Steatohepatitis (NASH) Sales by Country
8.6.2 South America Nonalcoholic Steatohepatitis (NASH) Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Nonalcoholic Steatohepatitis (NASH) Sales by Region
8.7.2 Middle East and Africa Nonalcoholic Steatohepatitis (NASH) Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 NONALCOHOLIC STEATOHEPATITIS (NASH) MARKET PRODUCTION BY REGION
9.1 Global Production of Nonalcoholic Steatohepatitis (NASH) by Region(2020-2025)
9.2 Global Nonalcoholic Steatohepatitis (NASH) Revenue Market Share by Region (2020-2025)
9.3 Global Nonalcoholic Steatohepatitis (NASH) Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Nonalcoholic Steatohepatitis (NASH) Production
9.4.1 North America Nonalcoholic Steatohepatitis (NASH) Production Growth Rate (2020-2025)
9.4.2 North America Nonalcoholic Steatohepatitis (NASH) Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Nonalcoholic Steatohepatitis (NASH) Production
9.5.1 Europe Nonalcoholic Steatohepatitis (NASH) Production Growth Rate (2020-2025)
9.5.2 Europe Nonalcoholic Steatohepatitis (NASH) Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Nonalcoholic Steatohepatitis (NASH) Production (2020-2025)
9.6.1 Japan Nonalcoholic Steatohepatitis (NASH) Production Growth Rate (2020-2025)
9.6.2 Japan Nonalcoholic Steatohepatitis (NASH) Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Nonalcoholic Steatohepatitis (NASH) Production (2020-2025)
9.7.1 China Nonalcoholic Steatohepatitis (NASH) Production Growth Rate (2020-2025)
9.7.2 China Nonalcoholic Steatohepatitis (NASH) Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 AstraZeneca
10.1.1 AstraZeneca Basic Information
10.1.2 AstraZeneca Nonalcoholic Steatohepatitis (NASH) Product Overview
10.1.3 AstraZeneca Nonalcoholic Steatohepatitis (NASH) Product Market Performance
10.1.4 AstraZeneca Business Overview
10.1.5 AstraZeneca SWOT Analysis
10.1.6 AstraZeneca Recent Developments
10.2 Arena Pharmaceuticals
10.2.1 Arena Pharmaceuticals Basic Information
10.2.2 Arena Pharmaceuticals Nonalcoholic Steatohepatitis (NASH) Product Overview
10.2.3 Arena Pharmaceuticals Nonalcoholic Steatohepatitis (NASH) Product Market Performance
10.2.4 Arena Pharmaceuticals Business Overview
10.2.5 Arena Pharmaceuticals SWOT Analysis
10.2.6 Arena Pharmaceuticals Recent Developments
10.3 GSK
10.3.1 GSK Basic Information
10.3.2 GSK Nonalcoholic Steatohepatitis (NASH) Product Overview
10.3.3 GSK Nonalcoholic Steatohepatitis (NASH) Product Market Performance
10.3.4 GSK Business Overview
10.3.5 GSK SWOT Analysis
10.3.6 GSK Recent Developments
10.4 Novo Nordisk
10.4.1 Novo Nordisk Basic Information
10.4.2 Novo Nordisk Nonalcoholic Steatohepatitis (NASH) Product Overview
10.4.3 Novo Nordisk Nonalcoholic Steatohepatitis (NASH) Product Market Performance
10.4.4 Novo Nordisk Business Overview
10.4.5 Novo Nordisk Recent Developments
10.5 Roche
10.5.1 Roche Basic Information
10.5.2 Roche Nonalcoholic Steatohepatitis (NASH) Product Overview
10.5.3 Roche Nonalcoholic Steatohepatitis (NASH) Product Market Performance
10.5.4 Roche Business Overview
10.5.5 Roche Recent Developments
10.6 Vivus
10.6.1 Vivus Basic Information
10.6.2 Vivus Nonalcoholic Steatohepatitis (NASH) Product Overview
10.6.3 Vivus Nonalcoholic Steatohepatitis (NASH) Product Market Performance
10.6.4 Vivus Business Overview
10.6.5 Vivus Recent Developments
10.7 Arisaph Pharmaceuticals
10.7.1 Arisaph Pharmaceuticals Basic Information
10.7.2 Arisaph Pharmaceuticals Nonalcoholic Steatohepatitis (NASH) Product Overview
10.7.3 Arisaph Pharmaceuticals Nonalcoholic Steatohepatitis (NASH) Product Market Performance
10.7.4 Arisaph Pharmaceuticals Business Overview
10.7.5 Arisaph Pharmaceuticals Recent Developments
10.8 Cempra Pharmaceuticals
10.8.1 Cempra Pharmaceuticals Basic Information
10.8.2 Cempra Pharmaceuticals Nonalcoholic Steatohepatitis (NASH) Product Overview
10.8.3 Cempra Pharmaceuticals Nonalcoholic Steatohepatitis (NASH) Product Market Performance
10.8.4 Cempra Pharmaceuticals Business Overview
10.8.5 Cempra Pharmaceuticals Recent Developments
10.9 Galectin Therapeutics
10.9.1 Galectin Therapeutics Basic Information
10.9.2 Galectin Therapeutics Nonalcoholic Steatohepatitis (NASH) Product Overview
10.9.3 Galectin Therapeutics Nonalcoholic Steatohepatitis (NASH) Product Market Performance
10.9.4 Galectin Therapeutics Business Overview
10.9.5 Galectin Therapeutics Recent Developments
10.10 Galmed Pharmaceuticals
10.10.1 Galmed Pharmaceuticals Basic Information
10.10.2 Galmed Pharmaceuticals Nonalcoholic Steatohepatitis (NASH) Product Overview
10.10.3 Galmed Pharmaceuticals Nonalcoholic Steatohepatitis (NASH) Product Market Performance
10.10.4 Galmed Pharmaceuticals Business Overview
10.10.5 Galmed Pharmaceuticals Recent Developments
10.11 Genfit
10.11.1 Genfit Basic Information
10.11.2 Genfit Nonalcoholic Steatohepatitis (NASH) Product Overview
10.11.3 Genfit Nonalcoholic Steatohepatitis (NASH) Product Market Performance
10.11.4 Genfit Business Overview
10.11.5 Genfit Recent Developments
10.12 Gilead
10.12.1 Gilead Basic Information
10.12.2 Gilead Nonalcoholic Steatohepatitis (NASH) Product Overview
10.12.3 Gilead Nonalcoholic Steatohepatitis (NASH) Product Market Performance
10.12.4 Gilead Business Overview
10.12.5 Gilead Recent Developments
11 NONALCOHOLIC STEATOHEPATITIS (NASH) MARKET FORECAST BY REGION
11.1 Global Nonalcoholic Steatohepatitis (NASH) Market Size Forecast
11.2 Global Nonalcoholic Steatohepatitis (NASH) Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Nonalcoholic Steatohepatitis (NASH) Market Size Forecast by Country
11.2.3 Asia Pacific Nonalcoholic Steatohepatitis (NASH) Market Size Forecast by Region
11.2.4 South America Nonalcoholic Steatohepatitis (NASH) Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Nonalcoholic Steatohepatitis (NASH) by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Nonalcoholic Steatohepatitis (NASH) Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Nonalcoholic Steatohepatitis (NASH) by Type (2026-2035)
12.1.2 Global Nonalcoholic Steatohepatitis (NASH) Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Nonalcoholic Steatohepatitis (NASH) by Type (2026-2035)
12.2 Global Nonalcoholic Steatohepatitis (NASH) Market Forecast by Application (2026-2035)
12.2.1 Global Nonalcoholic Steatohepatitis (NASH) Sales (K Units) Forecast by Application
12.2.2 Global Nonalcoholic Steatohepatitis (NASH) Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Nonalcoholic Steatohepatitis (NASH) Market Size by Type (M USD)
Table 4. Global Nonalcoholic Steatohepatitis (NASH) Market Size by Application
Table 5. Nonalcoholic Steatohepatitis (NASH) Market Size Comparison by Region (M USD)
Table 6. Global Nonalcoholic Steatohepatitis (NASH) Sales (K Units) by Manufacturers (2020-2025)
Table 7. Global Nonalcoholic Steatohepatitis (NASH) Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Nonalcoholic Steatohepatitis (NASH) Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Nonalcoholic Steatohepatitis (NASH) Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nonalcoholic Steatohepatitis (NASH) as of 2025)
Table 11. Global Market Nonalcoholic Steatohepatitis (NASH) Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Nonalcoholic Steatohepatitis (NASH) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Nonalcoholic Steatohepatitis (NASH) Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Nonalcoholic Steatohepatitis (NASH) Sales by Type (K Units)
Table 27. Global Nonalcoholic Steatohepatitis (NASH) Market Size by Type (M USD)
Table 28. Global Nonalcoholic Steatohepatitis (NASH) Sales (K Units) by Type (2020-2025)
Table 29. Global Nonalcoholic Steatohepatitis (NASH) Sales Market Share by Type (2020-2025)
Table 30. Global Nonalcoholic Steatohepatitis (NASH) Market Size (M USD) by Type (2020-2025)
Table 31. Global Nonalcoholic Steatohepatitis (NASH) Market Share by Type (2020-2025)
Table 32. Global Nonalcoholic Steatohepatitis (NASH) Price (USD/Unit) by Type (2020-2025)
Table 33. Global Nonalcoholic Steatohepatitis (NASH) Sales (K Units) by Application
Table 34. Global Nonalcoholic Steatohepatitis (NASH) Market Size by Application
Table 35. Global Nonalcoholic Steatohepatitis (NASH) Sales by Application (2020-2025) & (K Units)
Table 36. Global Nonalcoholic Steatohepatitis (NASH) Sales Market Share by Application (2020-2025)
Table 37. Global Nonalcoholic Steatohepatitis (NASH) Market Size by Application (2020-2025) & (M USD)
Table 38. Global Nonalcoholic Steatohepatitis (NASH) Market Share by Application (2020-2025)
Table 39. Global Nonalcoholic Steatohepatitis (NASH) Sales Growth Rate by Application (2020-2025)
Table 40. Global Nonalcoholic Steatohepatitis (NASH) Sales by Region (2020-2025) & (K Units)
Table 41. Global Nonalcoholic Steatohepatitis (NASH) Sales Market Share by Region (2020-2025)
Table 42. Global Nonalcoholic Steatohepatitis (NASH) Market Size by Region (2020-2025) & (M USD)
Table 43. Global Nonalcoholic Steatohepatitis (NASH) Market Size by Region (2020-2025)
Table 44. North America Nonalcoholic Steatohepatitis (NASH) Sales by Country (2020-2025) & (K Units)
Table 45. North America Nonalcoholic Steatohepatitis (NASH) Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Nonalcoholic Steatohepatitis (NASH) Sales by Country (2020-2025) & (K Units)
Table 47. Europe Nonalcoholic Steatohepatitis (NASH) Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Nonalcoholic Steatohepatitis (NASH) Sales by Region (2020-2025) & (K Units)
Table 49. Asia Pacific Nonalcoholic Steatohepatitis (NASH) Market Size by Region (2020-2025) & (M USD)
Table 50. South America Nonalcoholic Steatohepatitis (NASH) Sales by Country (2020-2025) & (K Units)
Table 51. South America Nonalcoholic Steatohepatitis (NASH) Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Nonalcoholic Steatohepatitis (NASH) Sales by Region (2020-2025) & (K Units)
Table 53. Middle East and Africa Nonalcoholic Steatohepatitis (NASH) Market Size by Region (2020-2025) & (M USD)
Table 54. Global Nonalcoholic Steatohepatitis (NASH) Production (K Units) by Region(2020-2025)
Table 55. Global Nonalcoholic Steatohepatitis (NASH) Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Nonalcoholic Steatohepatitis (NASH) Revenue Market Share by Region (2020-2025)
Table 57. Global Nonalcoholic Steatohepatitis (NASH) Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. North America Nonalcoholic Steatohepatitis (NASH) Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. Europe Nonalcoholic Steatohepatitis (NASH) Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. Japan Nonalcoholic Steatohepatitis (NASH) Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 61. China Nonalcoholic Steatohepatitis (NASH) Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 62. AstraZeneca Basic Information
Table 63. AstraZeneca Nonalcoholic Steatohepatitis (NASH) Product Overview
Table 64. AstraZeneca Nonalcoholic Steatohepatitis (NASH) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 65. AstraZeneca Business Overview
Table 66. AstraZeneca SWOT Analysis
Table 67. AstraZeneca Recent Developments
Table 68. Arena Pharmaceuticals Basic Information
Table 69. Arena Pharmaceuticals Nonalcoholic Steatohepatitis (NASH) Product Overview
Table 70. Arena Pharmaceuticals Nonalcoholic Steatohepatitis (NASH) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 71. Arena Pharmaceuticals Business Overview
Table 72. Arena Pharmaceuticals SWOT Analysis
Table 73. Arena Pharmaceuticals Recent Developments
Table 74. GSK Basic Information
Table 75. GSK Nonalcoholic Steatohepatitis (NASH) Product Overview
Table 76. GSK Nonalcoholic Steatohepatitis (NASH) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 77. GSK Business Overview
Table 78. GSK SWOT Analysis
Table 79. GSK Recent Developments
Table 80. Novo Nordisk Basic Information
Table 81. Novo Nordisk Nonalcoholic Steatohepatitis (NASH) Product Overview
Table 82. Novo Nordisk Nonalcoholic Steatohepatitis (NASH) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. Novo Nordisk Business Overview
Table 84. Novo Nordisk Recent Developments
Table 85. Roche Basic Information
Table 86. Roche Nonalcoholic Steatohepatitis (NASH) Product Overview
Table 87. Roche Nonalcoholic Steatohepatitis (NASH) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. Roche Business Overview
Table 89. Roche Recent Developments
Table 90. Vivus Basic Information
Table 91. Vivus Nonalcoholic Steatohepatitis (NASH) Product Overview
Table 92. Vivus Nonalcoholic Steatohepatitis (NASH) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 93. Vivus Business Overview
Table 94. Vivus Recent Developments
Table 95. Arisaph Pharmaceuticals Basic Information
Table 96. Arisaph Pharmaceuticals Nonalcoholic Steatohepatitis (NASH) Product Overview
Table 97. Arisaph Pharmaceuticals Nonalcoholic Steatohepatitis (NASH) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 98. Arisaph Pharmaceuticals Business Overview
Table 99. Arisaph Pharmaceuticals Recent Developments
Table 100. Cempra Pharmaceuticals Basic Information
Table 101. Cempra Pharmaceuticals Nonalcoholic Steatohepatitis (NASH) Product Overview
Table 102. Cempra Pharmaceuticals Nonalcoholic Steatohepatitis (NASH) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 103. Cempra Pharmaceuticals Business Overview
Table 104. Cempra Pharmaceuticals Recent Developments
Table 105. Galectin Therapeutics Basic Information
Table 106. Galectin Therapeutics Nonalcoholic Steatohepatitis (NASH) Product Overview
Table 107. Galectin Therapeutics Nonalcoholic Steatohepatitis (NASH) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 108. Galectin Therapeutics Business Overview
Table 109. Galectin Therapeutics Recent Developments
Table 110. Galmed Pharmaceuticals Basic Information
Table 111. Galmed Pharmaceuticals Nonalcoholic Steatohepatitis (NASH) Product Overview
Table 112. Galmed Pharmaceuticals Nonalcoholic Steatohepatitis (NASH) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 113. Galmed Pharmaceuticals Business Overview
Table 114. Galmed Pharmaceuticals Recent Developments
Table 115. Genfit Basic Information
Table 116. Genfit Nonalcoholic Steatohepatitis (NASH) Product Overview
Table 117. Genfit Nonalcoholic Steatohepatitis (NASH) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 118. Genfit Business Overview
Table 119. Genfit Recent Developments
Table 120. Gilead Basic Information
Table 121. Gilead Nonalcoholic Steatohepatitis (NASH) Product Overview
Table 122. Gilead Nonalcoholic Steatohepatitis (NASH) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 123. Gilead Business Overview
Table 124. Gilead Recent Developments
Table 125. Global Nonalcoholic Steatohepatitis (NASH) Sales Forecast by Region (2026-2035) & (K Units)
Table 126. Global Nonalcoholic Steatohepatitis (NASH) Market Size Forecast by Region (2026-2035) & (M USD)
Table 127. North America Nonalcoholic Steatohepatitis (NASH) Sales Forecast by Country (2026-2035) & (K Units)
Table 128. North America Nonalcoholic Steatohepatitis (NASH) Market Size Forecast by Country (2026-2035) & (M USD)
Table 129. Europe Nonalcoholic Steatohepatitis (NASH) Sales Forecast by Country (2026-2035) & (K Units)
Table 130. Europe Nonalcoholic Steatohepatitis (NASH) Market Size Forecast by Country (2026-2035) & (M USD)
Table 131. Asia Pacific Nonalcoholic Steatohepatitis (NASH) Sales Forecast by Region (2026-2035) & (K Units)
Table 132. Asia Pacific Nonalcoholic Steatohepatitis (NASH) Market Size Forecast by Region (2026-2035) & (M USD)
Table 133. South America Nonalcoholic Steatohepatitis (NASH) Sales Forecast by Country (2026-2035) & (K Units)
Table 134. South America Nonalcoholic Steatohepatitis (NASH) Market Size Forecast by Country (2026-2035) & (M USD)
Table 135. Middle East and Africa Nonalcoholic Steatohepatitis (NASH) Sales Forecast by Country (2026-2035) & (Units)
Table 136. Middle East and Africa Nonalcoholic Steatohepatitis (NASH) Market Size Forecast by Country (2026-2035) & (M USD)
Table 137. Global Nonalcoholic Steatohepatitis (NASH) Sales Forecast by Type (2026-2035) & (K Units)
Table 138. Global Nonalcoholic Steatohepatitis (NASH) Market Size Forecast by Type (2026-2035) & (M USD)
Table 139. Global Nonalcoholic Steatohepatitis (NASH) Price Forecast by Type (2026-2035) & (USD/Unit)
Table 140. Global Nonalcoholic Steatohepatitis (NASH) Sales (K Units) Forecast by Application (2026-2035)
Table 141. Global Nonalcoholic Steatohepatitis (NASH) Market Size Forecast by Application (2026-2035) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Nonalcoholic Steatohepatitis (NASH) Market Size by Type (M USD)
Table 4. Global Nonalcoholic Steatohepatitis (NASH) Market Size by Application
Table 5. Nonalcoholic Steatohepatitis (NASH) Market Size Comparison by Region (M USD)
Table 6. Global Nonalcoholic Steatohepatitis (NASH) Sales (K Units) by Manufacturers (2020-2025)
Table 7. Global Nonalcoholic Steatohepatitis (NASH) Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Nonalcoholic Steatohepatitis (NASH) Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Nonalcoholic Steatohepatitis (NASH) Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nonalcoholic Steatohepatitis (NASH) as of 2025)
Table 11. Global Market Nonalcoholic Steatohepatitis (NASH) Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Nonalcoholic Steatohepatitis (NASH) Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Nonalcoholic Steatohepatitis (NASH) Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Nonalcoholic Steatohepatitis (NASH) Sales by Type (K Units)
Table 27. Global Nonalcoholic Steatohepatitis (NASH) Market Size by Type (M USD)
Table 28. Global Nonalcoholic Steatohepatitis (NASH) Sales (K Units) by Type (2020-2025)
Table 29. Global Nonalcoholic Steatohepatitis (NASH) Sales Market Share by Type (2020-2025)
Table 30. Global Nonalcoholic Steatohepatitis (NASH) Market Size (M USD) by Type (2020-2025)
Table 31. Global Nonalcoholic Steatohepatitis (NASH) Market Share by Type (2020-2025)
Table 32. Global Nonalcoholic Steatohepatitis (NASH) Price (USD/Unit) by Type (2020-2025)
Table 33. Global Nonalcoholic Steatohepatitis (NASH) Sales (K Units) by Application
Table 34. Global Nonalcoholic Steatohepatitis (NASH) Market Size by Application
Table 35. Global Nonalcoholic Steatohepatitis (NASH) Sales by Application (2020-2025) & (K Units)
Table 36. Global Nonalcoholic Steatohepatitis (NASH) Sales Market Share by Application (2020-2025)
Table 37. Global Nonalcoholic Steatohepatitis (NASH) Market Size by Application (2020-2025) & (M USD)
Table 38. Global Nonalcoholic Steatohepatitis (NASH) Market Share by Application (2020-2025)
Table 39. Global Nonalcoholic Steatohepatitis (NASH) Sales Growth Rate by Application (2020-2025)
Table 40. Global Nonalcoholic Steatohepatitis (NASH) Sales by Region (2020-2025) & (K Units)
Table 41. Global Nonalcoholic Steatohepatitis (NASH) Sales Market Share by Region (2020-2025)
Table 42. Global Nonalcoholic Steatohepatitis (NASH) Market Size by Region (2020-2025) & (M USD)
Table 43. Global Nonalcoholic Steatohepatitis (NASH) Market Size by Region (2020-2025)
Table 44. North America Nonalcoholic Steatohepatitis (NASH) Sales by Country (2020-2025) & (K Units)
Table 45. North America Nonalcoholic Steatohepatitis (NASH) Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Nonalcoholic Steatohepatitis (NASH) Sales by Country (2020-2025) & (K Units)
Table 47. Europe Nonalcoholic Steatohepatitis (NASH) Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Nonalcoholic Steatohepatitis (NASH) Sales by Region (2020-2025) & (K Units)
Table 49. Asia Pacific Nonalcoholic Steatohepatitis (NASH) Market Size by Region (2020-2025) & (M USD)
Table 50. South America Nonalcoholic Steatohepatitis (NASH) Sales by Country (2020-2025) & (K Units)
Table 51. South America Nonalcoholic Steatohepatitis (NASH) Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Nonalcoholic Steatohepatitis (NASH) Sales by Region (2020-2025) & (K Units)
Table 53. Middle East and Africa Nonalcoholic Steatohepatitis (NASH) Market Size by Region (2020-2025) & (M USD)
Table 54. Global Nonalcoholic Steatohepatitis (NASH) Production (K Units) by Region(2020-2025)
Table 55. Global Nonalcoholic Steatohepatitis (NASH) Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Nonalcoholic Steatohepatitis (NASH) Revenue Market Share by Region (2020-2025)
Table 57. Global Nonalcoholic Steatohepatitis (NASH) Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. North America Nonalcoholic Steatohepatitis (NASH) Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. Europe Nonalcoholic Steatohepatitis (NASH) Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. Japan Nonalcoholic Steatohepatitis (NASH) Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 61. China Nonalcoholic Steatohepatitis (NASH) Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 62. AstraZeneca Basic Information
Table 63. AstraZeneca Nonalcoholic Steatohepatitis (NASH) Product Overview
Table 64. AstraZeneca Nonalcoholic Steatohepatitis (NASH) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 65. AstraZeneca Business Overview
Table 66. AstraZeneca SWOT Analysis
Table 67. AstraZeneca Recent Developments
Table 68. Arena Pharmaceuticals Basic Information
Table 69. Arena Pharmaceuticals Nonalcoholic Steatohepatitis (NASH) Product Overview
Table 70. Arena Pharmaceuticals Nonalcoholic Steatohepatitis (NASH) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 71. Arena Pharmaceuticals Business Overview
Table 72. Arena Pharmaceuticals SWOT Analysis
Table 73. Arena Pharmaceuticals Recent Developments
Table 74. GSK Basic Information
Table 75. GSK Nonalcoholic Steatohepatitis (NASH) Product Overview
Table 76. GSK Nonalcoholic Steatohepatitis (NASH) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 77. GSK Business Overview
Table 78. GSK SWOT Analysis
Table 79. GSK Recent Developments
Table 80. Novo Nordisk Basic Information
Table 81. Novo Nordisk Nonalcoholic Steatohepatitis (NASH) Product Overview
Table 82. Novo Nordisk Nonalcoholic Steatohepatitis (NASH) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. Novo Nordisk Business Overview
Table 84. Novo Nordisk Recent Developments
Table 85. Roche Basic Information
Table 86. Roche Nonalcoholic Steatohepatitis (NASH) Product Overview
Table 87. Roche Nonalcoholic Steatohepatitis (NASH) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. Roche Business Overview
Table 89. Roche Recent Developments
Table 90. Vivus Basic Information
Table 91. Vivus Nonalcoholic Steatohepatitis (NASH) Product Overview
Table 92. Vivus Nonalcoholic Steatohepatitis (NASH) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 93. Vivus Business Overview
Table 94. Vivus Recent Developments
Table 95. Arisaph Pharmaceuticals Basic Information
Table 96. Arisaph Pharmaceuticals Nonalcoholic Steatohepatitis (NASH) Product Overview
Table 97. Arisaph Pharmaceuticals Nonalcoholic Steatohepatitis (NASH) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 98. Arisaph Pharmaceuticals Business Overview
Table 99. Arisaph Pharmaceuticals Recent Developments
Table 100. Cempra Pharmaceuticals Basic Information
Table 101. Cempra Pharmaceuticals Nonalcoholic Steatohepatitis (NASH) Product Overview
Table 102. Cempra Pharmaceuticals Nonalcoholic Steatohepatitis (NASH) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 103. Cempra Pharmaceuticals Business Overview
Table 104. Cempra Pharmaceuticals Recent Developments
Table 105. Galectin Therapeutics Basic Information
Table 106. Galectin Therapeutics Nonalcoholic Steatohepatitis (NASH) Product Overview
Table 107. Galectin Therapeutics Nonalcoholic Steatohepatitis (NASH) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 108. Galectin Therapeutics Business Overview
Table 109. Galectin Therapeutics Recent Developments
Table 110. Galmed Pharmaceuticals Basic Information
Table 111. Galmed Pharmaceuticals Nonalcoholic Steatohepatitis (NASH) Product Overview
Table 112. Galmed Pharmaceuticals Nonalcoholic Steatohepatitis (NASH) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 113. Galmed Pharmaceuticals Business Overview
Table 114. Galmed Pharmaceuticals Recent Developments
Table 115. Genfit Basic Information
Table 116. Genfit Nonalcoholic Steatohepatitis (NASH) Product Overview
Table 117. Genfit Nonalcoholic Steatohepatitis (NASH) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 118. Genfit Business Overview
Table 119. Genfit Recent Developments
Table 120. Gilead Basic Information
Table 121. Gilead Nonalcoholic Steatohepatitis (NASH) Product Overview
Table 122. Gilead Nonalcoholic Steatohepatitis (NASH) Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 123. Gilead Business Overview
Table 124. Gilead Recent Developments
Table 125. Global Nonalcoholic Steatohepatitis (NASH) Sales Forecast by Region (2026-2035) & (K Units)
Table 126. Global Nonalcoholic Steatohepatitis (NASH) Market Size Forecast by Region (2026-2035) & (M USD)
Table 127. North America Nonalcoholic Steatohepatitis (NASH) Sales Forecast by Country (2026-2035) & (K Units)
Table 128. North America Nonalcoholic Steatohepatitis (NASH) Market Size Forecast by Country (2026-2035) & (M USD)
Table 129. Europe Nonalcoholic Steatohepatitis (NASH) Sales Forecast by Country (2026-2035) & (K Units)
Table 130. Europe Nonalcoholic Steatohepatitis (NASH) Market Size Forecast by Country (2026-2035) & (M USD)
Table 131. Asia Pacific Nonalcoholic Steatohepatitis (NASH) Sales Forecast by Region (2026-2035) & (K Units)
Table 132. Asia Pacific Nonalcoholic Steatohepatitis (NASH) Market Size Forecast by Region (2026-2035) & (M USD)
Table 133. South America Nonalcoholic Steatohepatitis (NASH) Sales Forecast by Country (2026-2035) & (K Units)
Table 134. South America Nonalcoholic Steatohepatitis (NASH) Market Size Forecast by Country (2026-2035) & (M USD)
Table 135. Middle East and Africa Nonalcoholic Steatohepatitis (NASH) Sales Forecast by Country (2026-2035) & (Units)
Table 136. Middle East and Africa Nonalcoholic Steatohepatitis (NASH) Market Size Forecast by Country (2026-2035) & (M USD)
Table 137. Global Nonalcoholic Steatohepatitis (NASH) Sales Forecast by Type (2026-2035) & (K Units)
Table 138. Global Nonalcoholic Steatohepatitis (NASH) Market Size Forecast by Type (2026-2035) & (M USD)
Table 139. Global Nonalcoholic Steatohepatitis (NASH) Price Forecast by Type (2026-2035) & (USD/Unit)
Table 140. Global Nonalcoholic Steatohepatitis (NASH) Sales (K Units) Forecast by Application (2026-2035)
Table 141. Global Nonalcoholic Steatohepatitis (NASH) Market Size Forecast by Application (2026-2035) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Nonalcoholic Steatohepatitis (NASH)
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Nonalcoholic Steatohepatitis (NASH) Market Size (M USD), 2025-2035
Figure 5. Global Nonalcoholic Steatohepatitis (NASH) Market Size (M USD) (2020-2035)
Figure 6. Global Nonalcoholic Steatohepatitis (NASH) Sales (K Units) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Nonalcoholic Steatohepatitis (NASH) Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Nonalcoholic Steatohepatitis (NASH) Product Life Cycle
Figure 13. Nonalcoholic Steatohepatitis (NASH) Sales Share by Manufacturers in 2025
Figure 14. Global Nonalcoholic Steatohepatitis (NASH) Revenue Share by Manufacturers in 2025
Figure 15. Nonalcoholic Steatohepatitis (NASH) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Nonalcoholic Steatohepatitis (NASH) Average Price (USD/Unit) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Nonalcoholic Steatohepatitis (NASH) Revenue in 2025
Figure 18. Industry Chain Map of Nonalcoholic Steatohepatitis (NASH)
Figure 19. Global Nonalcoholic Steatohepatitis (NASH) Market PEST Analysis
Figure 20. Global Nonalcoholic Steatohepatitis (NASH) Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Nonalcoholic Steatohepatitis (NASH) Market Share by Type
Figure 27. Sales Market Share of Nonalcoholic Steatohepatitis (NASH) by Type (2020-2025)
Figure 28. Sales Market Share of Nonalcoholic Steatohepatitis (NASH) by Type in 2025
Figure 29. Market Share of Nonalcoholic Steatohepatitis (NASH) by Type (2020-2025)
Figure 30. Market Share of Nonalcoholic Steatohepatitis (NASH) by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Nonalcoholic Steatohepatitis (NASH) Market Share by Application
Figure 33. Global Nonalcoholic Steatohepatitis (NASH) Sales Market Share by Application (2020-2025)
Figure 34. Global Nonalcoholic Steatohepatitis (NASH) Sales Market Share by Application in 2025
Figure 35. Global Nonalcoholic Steatohepatitis (NASH) Market Share by Application (2020-2025)
Figure 36. Global Nonalcoholic Steatohepatitis (NASH) Market Share by Application in 2025
Figure 37. Global Nonalcoholic Steatohepatitis (NASH) Sales Growth Rate by Application (2020-2025)
Figure 38. Global Nonalcoholic Steatohepatitis (NASH) Sales Market Share by Region (2020-2025)
Figure 39. Global Nonalcoholic Steatohepatitis (NASH) Market Size by Region (2020-2025)
Figure 40. North America Nonalcoholic Steatohepatitis (NASH) Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America Nonalcoholic Steatohepatitis (NASH) Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America Nonalcoholic Steatohepatitis (NASH) Sales Market Share by Country in 2024
Figure 43. North America Nonalcoholic Steatohepatitis (NASH) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Nonalcoholic Steatohepatitis (NASH) Market Size by Country in 2024
Figure 45. U.S. Nonalcoholic Steatohepatitis (NASH) Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. Nonalcoholic Steatohepatitis (NASH) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Nonalcoholic Steatohepatitis (NASH) Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada Nonalcoholic Steatohepatitis (NASH) Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Nonalcoholic Steatohepatitis (NASH) Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Nonalcoholic Steatohepatitis (NASH) Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Nonalcoholic Steatohepatitis (NASH) Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe Nonalcoholic Steatohepatitis (NASH) Sales Market Share by Country in 2024
Figure 53. Europe Nonalcoholic Steatohepatitis (NASH) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Nonalcoholic Steatohepatitis (NASH) Market Size by Country in 2024
Figure 55. Germany Nonalcoholic Steatohepatitis (NASH) Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany Nonalcoholic Steatohepatitis (NASH) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Nonalcoholic Steatohepatitis (NASH) Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France Nonalcoholic Steatohepatitis (NASH) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Nonalcoholic Steatohepatitis (NASH) Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. Nonalcoholic Steatohepatitis (NASH) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Nonalcoholic Steatohepatitis (NASH) Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy Nonalcoholic Steatohepatitis (NASH) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Nonalcoholic Steatohepatitis (NASH) Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain Nonalcoholic Steatohepatitis (NASH) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Nonalcoholic Steatohepatitis (NASH) Sales and Growth Rate (K Units)
Figure 66. Asia Pacific Nonalcoholic Steatohepatitis (NASH) Sales Market Share by Region in 2024
Figure 67. Asia Pacific Nonalcoholic Steatohepatitis (NASH) Market Size by Region in 2024
Figure 68. China Nonalcoholic Steatohepatitis (NASH) Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China Nonalcoholic Steatohepatitis (NASH) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Nonalcoholic Steatohepatitis (NASH) Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan Nonalcoholic Steatohepatitis (NASH) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Nonalcoholic Steatohepatitis (NASH) Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea Nonalcoholic Steatohepatitis (NASH) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Nonalcoholic Steatohepatitis (NASH) Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India Nonalcoholic Steatohepatitis (NASH) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Nonalcoholic Steatohepatitis (NASH) Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia Nonalcoholic Steatohepatitis (NASH) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Nonalcoholic Steatohepatitis (NASH) Sales and Growth Rate (K Units)
Figure 79. South America Nonalcoholic Steatohepatitis (NASH) Sales Market Share by Country in 2024
Figure 80. South America Nonalcoholic Steatohepatitis (NASH) Market Size and Growth Rate (M USD)
Figure 81. South America Nonalcoholic Steatohepatitis (NASH) Market Size by Country in 2024
Figure 82. Brazil Nonalcoholic Steatohepatitis (NASH) Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil Nonalcoholic Steatohepatitis (NASH) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Nonalcoholic Steatohepatitis (NASH) Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina Nonalcoholic Steatohepatitis (NASH) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Nonalcoholic Steatohepatitis (NASH) Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia Nonalcoholic Steatohepatitis (NASH) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Nonalcoholic Steatohepatitis (NASH) Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa Nonalcoholic Steatohepatitis (NASH) Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Nonalcoholic Steatohepatitis (NASH) Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Nonalcoholic Steatohepatitis (NASH) Market Size by Region in 2024
Figure 92. Saudi Arabia Nonalcoholic Steatohepatitis (NASH) Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia Nonalcoholic Steatohepatitis (NASH) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Nonalcoholic Steatohepatitis (NASH) Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE Nonalcoholic Steatohepatitis (NASH) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Nonalcoholic Steatohepatitis (NASH) Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt Nonalcoholic Steatohepatitis (NASH) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Nonalcoholic Steatohepatitis (NASH) Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria Nonalcoholic Steatohepatitis (NASH) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Nonalcoholic Steatohepatitis (NASH) Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa Nonalcoholic Steatohepatitis (NASH) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Nonalcoholic Steatohepatitis (NASH) Production Market Share by Region (2020-2025)
Figure 103. North America Nonalcoholic Steatohepatitis (NASH) Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe Nonalcoholic Steatohepatitis (NASH) Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan Nonalcoholic Steatohepatitis (NASH) Production (K Units) Growth Rate (2020-2025)
Figure 106. China Nonalcoholic Steatohepatitis (NASH) Production (K Units) Growth Rate (2020-2025)
Figure 107. Global Nonalcoholic Steatohepatitis (NASH) Sales Forecast by Volume (2020-2035) & (K Units)
Figure 108. Global Nonalcoholic Steatohepatitis (NASH) Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Nonalcoholic Steatohepatitis (NASH) Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Nonalcoholic Steatohepatitis (NASH) Market Share Forecast by Type (2026-2035)
Figure 111. Global Nonalcoholic Steatohepatitis (NASH) Sales Forecast by Application (2026-2035)
Figure 112. Global Nonalcoholic Steatohepatitis (NASH) Market Share Forecast by Application (2026-2035)
Figure 1. Product Picture of Nonalcoholic Steatohepatitis (NASH)
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Nonalcoholic Steatohepatitis (NASH) Market Size (M USD), 2025-2035
Figure 5. Global Nonalcoholic Steatohepatitis (NASH) Market Size (M USD) (2020-2035)
Figure 6. Global Nonalcoholic Steatohepatitis (NASH) Sales (K Units) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Nonalcoholic Steatohepatitis (NASH) Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Nonalcoholic Steatohepatitis (NASH) Product Life Cycle
Figure 13. Nonalcoholic Steatohepatitis (NASH) Sales Share by Manufacturers in 2025
Figure 14. Global Nonalcoholic Steatohepatitis (NASH) Revenue Share by Manufacturers in 2025
Figure 15. Nonalcoholic Steatohepatitis (NASH) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Nonalcoholic Steatohepatitis (NASH) Average Price (USD/Unit) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Nonalcoholic Steatohepatitis (NASH) Revenue in 2025
Figure 18. Industry Chain Map of Nonalcoholic Steatohepatitis (NASH)
Figure 19. Global Nonalcoholic Steatohepatitis (NASH) Market PEST Analysis
Figure 20. Global Nonalcoholic Steatohepatitis (NASH) Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Nonalcoholic Steatohepatitis (NASH) Market Share by Type
Figure 27. Sales Market Share of Nonalcoholic Steatohepatitis (NASH) by Type (2020-2025)
Figure 28. Sales Market Share of Nonalcoholic Steatohepatitis (NASH) by Type in 2025
Figure 29. Market Share of Nonalcoholic Steatohepatitis (NASH) by Type (2020-2025)
Figure 30. Market Share of Nonalcoholic Steatohepatitis (NASH) by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Nonalcoholic Steatohepatitis (NASH) Market Share by Application
Figure 33. Global Nonalcoholic Steatohepatitis (NASH) Sales Market Share by Application (2020-2025)
Figure 34. Global Nonalcoholic Steatohepatitis (NASH) Sales Market Share by Application in 2025
Figure 35. Global Nonalcoholic Steatohepatitis (NASH) Market Share by Application (2020-2025)
Figure 36. Global Nonalcoholic Steatohepatitis (NASH) Market Share by Application in 2025
Figure 37. Global Nonalcoholic Steatohepatitis (NASH) Sales Growth Rate by Application (2020-2025)
Figure 38. Global Nonalcoholic Steatohepatitis (NASH) Sales Market Share by Region (2020-2025)
Figure 39. Global Nonalcoholic Steatohepatitis (NASH) Market Size by Region (2020-2025)
Figure 40. North America Nonalcoholic Steatohepatitis (NASH) Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America Nonalcoholic Steatohepatitis (NASH) Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America Nonalcoholic Steatohepatitis (NASH) Sales Market Share by Country in 2024
Figure 43. North America Nonalcoholic Steatohepatitis (NASH) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Nonalcoholic Steatohepatitis (NASH) Market Size by Country in 2024
Figure 45. U.S. Nonalcoholic Steatohepatitis (NASH) Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. Nonalcoholic Steatohepatitis (NASH) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Nonalcoholic Steatohepatitis (NASH) Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada Nonalcoholic Steatohepatitis (NASH) Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Nonalcoholic Steatohepatitis (NASH) Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Nonalcoholic Steatohepatitis (NASH) Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Nonalcoholic Steatohepatitis (NASH) Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe Nonalcoholic Steatohepatitis (NASH) Sales Market Share by Country in 2024
Figure 53. Europe Nonalcoholic Steatohepatitis (NASH) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Nonalcoholic Steatohepatitis (NASH) Market Size by Country in 2024
Figure 55. Germany Nonalcoholic Steatohepatitis (NASH) Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany Nonalcoholic Steatohepatitis (NASH) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Nonalcoholic Steatohepatitis (NASH) Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France Nonalcoholic Steatohepatitis (NASH) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Nonalcoholic Steatohepatitis (NASH) Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. Nonalcoholic Steatohepatitis (NASH) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Nonalcoholic Steatohepatitis (NASH) Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy Nonalcoholic Steatohepatitis (NASH) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Nonalcoholic Steatohepatitis (NASH) Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain Nonalcoholic Steatohepatitis (NASH) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Nonalcoholic Steatohepatitis (NASH) Sales and Growth Rate (K Units)
Figure 66. Asia Pacific Nonalcoholic Steatohepatitis (NASH) Sales Market Share by Region in 2024
Figure 67. Asia Pacific Nonalcoholic Steatohepatitis (NASH) Market Size by Region in 2024
Figure 68. China Nonalcoholic Steatohepatitis (NASH) Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China Nonalcoholic Steatohepatitis (NASH) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Nonalcoholic Steatohepatitis (NASH) Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan Nonalcoholic Steatohepatitis (NASH) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Nonalcoholic Steatohepatitis (NASH) Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea Nonalcoholic Steatohepatitis (NASH) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Nonalcoholic Steatohepatitis (NASH) Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India Nonalcoholic Steatohepatitis (NASH) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Nonalcoholic Steatohepatitis (NASH) Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia Nonalcoholic Steatohepatitis (NASH) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Nonalcoholic Steatohepatitis (NASH) Sales and Growth Rate (K Units)
Figure 79. South America Nonalcoholic Steatohepatitis (NASH) Sales Market Share by Country in 2024
Figure 80. South America Nonalcoholic Steatohepatitis (NASH) Market Size and Growth Rate (M USD)
Figure 81. South America Nonalcoholic Steatohepatitis (NASH) Market Size by Country in 2024
Figure 82. Brazil Nonalcoholic Steatohepatitis (NASH) Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil Nonalcoholic Steatohepatitis (NASH) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Nonalcoholic Steatohepatitis (NASH) Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina Nonalcoholic Steatohepatitis (NASH) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Nonalcoholic Steatohepatitis (NASH) Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia Nonalcoholic Steatohepatitis (NASH) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Nonalcoholic Steatohepatitis (NASH) Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa Nonalcoholic Steatohepatitis (NASH) Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Nonalcoholic Steatohepatitis (NASH) Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Nonalcoholic Steatohepatitis (NASH) Market Size by Region in 2024
Figure 92. Saudi Arabia Nonalcoholic Steatohepatitis (NASH) Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia Nonalcoholic Steatohepatitis (NASH) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Nonalcoholic Steatohepatitis (NASH) Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE Nonalcoholic Steatohepatitis (NASH) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Nonalcoholic Steatohepatitis (NASH) Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt Nonalcoholic Steatohepatitis (NASH) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Nonalcoholic Steatohepatitis (NASH) Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria Nonalcoholic Steatohepatitis (NASH) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Nonalcoholic Steatohepatitis (NASH) Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa Nonalcoholic Steatohepatitis (NASH) Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Nonalcoholic Steatohepatitis (NASH) Production Market Share by Region (2020-2025)
Figure 103. North America Nonalcoholic Steatohepatitis (NASH) Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe Nonalcoholic Steatohepatitis (NASH) Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan Nonalcoholic Steatohepatitis (NASH) Production (K Units) Growth Rate (2020-2025)
Figure 106. China Nonalcoholic Steatohepatitis (NASH) Production (K Units) Growth Rate (2020-2025)
Figure 107. Global Nonalcoholic Steatohepatitis (NASH) Sales Forecast by Volume (2020-2035) & (K Units)
Figure 108. Global Nonalcoholic Steatohepatitis (NASH) Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Nonalcoholic Steatohepatitis (NASH) Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Nonalcoholic Steatohepatitis (NASH) Market Share Forecast by Type (2026-2035)
Figure 111. Global Nonalcoholic Steatohepatitis (NASH) Sales Forecast by Application (2026-2035)
Figure 112. Global Nonalcoholic Steatohepatitis (NASH) Market Share Forecast by Application (2026-2035)
